Nephros (NEPH) Debt to Equity (2010 - 2022)

Nephros' Debt to Equity history runs 9 years deep, the most recent figure standing at $0.02 for Q4 2022.

• In Q4 2022, Debt to Equity fell 17.21% year-over-year to $0.02; the TTM figure through Dec 2022 stood at $0.02 (down 17.21% YoY), while the FY2022 annual figure was $0.02, down 17.21% from the prior year.
• Debt to Equity was $0.02 for Q4 2022 at Nephros, up from $0.01 in the prior quarter.
• In the past five years, Debt to Equity ranged from a high of $0.61 in Q1 2018 to a low of $0.01 in Q3 2020.
• Historically, Debt to Equity has averaged $0.12 across 5 years, with a median of $0.05 in 2020.
• The sharpest annual moves came in 2020 and 2021: Debt to Equity slumped 94.78% in 2020, then soared 106.61% in 2021.
• A 5-year view of Debt to Equity shows it stood at $0.15 in 2018, then slipped by 29.82% to $0.11 in 2019, then tumbled by 57.4% to $0.05 in 2020, then plunged by 49.06% to $0.02 in 2021, then decreased by 17.21% to $0.02 in 2022.
• The last three Debt to Equity figures came in at $0.02 (Q4 2022), $0.01 (Q3 2022), and $0.03 (Q2 2022), per Business Quant data.